Overview | Day 1 | Day 2 | Download Brochure

Register for the Executive Summit on Strategy and Innovation

Presenting and Invited Organizations

• AAIPharma, Inc.
• Amarin Corporation
• AstraZeneca
• Avesthagen, Inc.
• Chikujee Therapeutics
• Colby Pharmaceuticals
• Collaborative Drug Discovery, Inc.
• Critical Path Institute
• GlaxoSmithKline
• KAI Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Roche Diagnostics GmbH
• UCLA
• University of Pittsburgh
• Vicus Therapeutics
• and more!

Highlights Include

• Peer to peer discussions and networking, case studies and analysis, and interactive breakout sessions
• ‘Boot camp’ style summit providing participants the ability to enhance their problem-solving abilities to have REAL take-a-ways to share with 
  their colleagues back at the office
• Reflective sessions to incorporate ideas and feedback - summary debrief provided post conference to attendees
• Executive Summit Networking Luncheon
• Participants who wish to extend their education may attend any Molecular Medicine Tri-Conference sessions on Friday, February 27, including: Molecular Diagnostics, Mastering Medicinal Chemistry, Stem Cells Congress, Preclinical Drug Safety, Preclinical Development of Biologics, Translational Medicine, Cancer Profiling and Pathways, Adopting Integrated R&D Informatics Systems, Cancer Molecular Markers and Companion Diagnostics
• View over 160 exhibiting companies with lateral tools and services in Molecular Medicine

PLENARY KEYNOTE SPEAKER

David Ewing Duncan, Chief Correspondent of NPR Talk’s “Biotech Nation” and best-selling Author, “Masterminds”

Themes:

• Leading Through Disruption and Transformation
• Diversifying Product/Service Portfolios
• Expanding R&D Efficiencies
• Developing New Partner/Alliance/Collaboration Models
• Implementing Novel Approaches towards Product Commercialization
• International Partnerships

Summit Talks Include

• Competing in the Dynamic Economy of the 21st Century: Challenges and Opportunities
• Inventing New Ways to Think About IP: Time for an IP Share Market?
• Adapting an Organization to Focus on Innovation & IP Management
• Drug Repurposing Strategies/Next Generation Blockbusters
• Diversification of Product Portfolio
• Cost-risk-value Optimization – A New Model that Leads to Greater R&D Efficiency
• Deploying Enterprise 2.0 Solutions: Case Studies & Business Challenges
• Innovative Collaboration Models to Achieve Competitive Advantage
• Partnering with Companies from Other Countries
• Building Sustainable Value through International Partnerships
• Critical Path Program - Current Status
• Strategies and Novel Approaches Toward Product Line Extension
• Improving Pharmaceutical R&D Productivity to Sustain Value for Stakeholders

About
The Executive Summit is designed for qualified research & development, finance or business manager and executive audience who are considering or need innovative ideas, solutions and contacts for enhancing their current or evolving business models. In light of industry changes and the world recession, this Summit will provide finance persons, managers and executives successful strategies to help their organizations manage change in the marketplace, maintain sustainability and revenues with a strong pipeline of products and services, remain profitable, and build or sustain a high reputation and valuation.

The Summit is designed in a ‘boot-camp’ style format. A case analysis on disruption, transformation, and innovation kicks-off the first session. The remaining sessions are case studies that build upon the case analysis. Case studies focus on these themes: 1) diversifying product/service portfolios, 2) expanding R&D efficiencies, 3) developing new and multiple partner/alliance/collaboration models, 4) international partnerships, and 5) implementing novel approaches towards product commercialization. Debrief sessions will be held to share knowledge and ideas heard throughout the program. A compendium of these ideas will be distributed after the program. An exclusive Summit networking luncheon with executive participants and speakers will be held on Thursday.

Summit participants are invited to attend additional Tri-conference activities including the plenary keynotes and exhibit hall featuring 160 companies on Tuesday and Wednesday, well as track sessions on Friday. The Summit is an opportunity for a qualified executive audience to gather, share, and network within the larger Tri-conference program. 

Audience Criteria
The Executive Summit on Strategy and Innovation is open to qualified attendees only - directors and higher from pharmaceutical and biotechnology organizations; senior faculty at research universities and institutes; government agencies, and Summit sponsors. Participants of the Summit are an important, elite and growing group of individuals that are carefully screened to ensure that all in attendance meet the appropriate criteria necessary to be included and will be encouraged to interact.

Overview | Day 1 | Day 2 | Download Brochure

For questions or suggestions about the meeting, please contact:
Cindy Crowninshield
Cambridge Healthtech Institute
Tel: 781-354-0120
email: ccrowninshield@healthtech.com

For sponsorship and exhibit sales information, please contact:
Arnold Wolfson
Cambridge Healthtech Institute
Phone: 781-972-5431
Email: awolfson@healthtech.com